HONG KONG, Nov. 27 /PRNewswire-Asia-FirstCall/ -- China's leading integrated medical device and healthcare services provider, Golden Meditech Company Limited ("Golden Meditech" or "the Company", Stock Code: 8180.HK) is pleased to announce today that the Company has successfully brought in Atlantis Investment Management Limited ("Atlantis Investment") as financial investors through an allocation of 60 million new ordinary shares at a price HK$1.03 per share.
Mr. KAM Yuen, Chairman and CEO of Golden Meditech, said that despite the global financial crisis has caused extreme volatility in the capital market that resulted in numerous companies' fundamentals being casually ignored, Golden Meditech has demonstrated its ability to bring in new financial investor. It represents a vote of confidence from the investment community and a conviction of Golden Meditech strong fundamentals and promising outlook which was temporarily overshadowed by the pessimism in the capital market.
"We are honored to see that Atlantis Investment shares the same vision as we do with China's burgeoning healthcare industry and such a strategic investor-ship will not only strengthen Golden Meditech shareholders base, but also be beneficial to our long-term growth," said Mr. KAM.
"To act in the best interest of our shareholders, Golden Meditech has always been striving to maximize shareholders value. While enhancing the shareholder value, we also engage in various defensive measures, including share repurchases, for the purpose of preserving shareholder value," said Mr. KAM.
The net proceeds raised will be used for general working capital, and to fund future investment opportunities.
As of September 20, 2008, Golden Meditech reported sustained high growth of key businesses and recorded revenues of HK$241 million in the first half of financial year 2008/09, representing a 27% growth on a year on year basis. Net profit attributable to shareholders of the same period was HK$147 million.
Golden Meditech: Founded in 2000 and listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited in December 2001, Golden Meditech is the first hi-tech medical device enterprise that went public outside of the PRC. During the past few years, thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing the emerging market opportunities, Golden Meditech's medical devices, cord blood banking services and natural herbal medicines have all established dominant positions in their own sectors. Going forward, Golden Meditech will continue its pursuit of becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.
Atlantis Investment Management Limited: an independent Asian equity asset management firm with over US$4.5bn under management as at January 31, 2008, with a focus on China and the Asia-Pacific countries.
For inquiries, please kindly contact: Investor Relations Division Golden Meditech Company Limited Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong. Tel: +852-3605-8138 Fax: +852-3605-8181 Email: firstname.lastname@example.org
|SOURCE Golden Meditech Company Limited|
Copyright©2008 PR Newswire.
All rights reserved